[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100213607":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":23,"centralContacts":28,"locations":35,"responsibleParty":131,"collaborators":133,"id":136,"slug":137,"hasResults":138,"nctId":139,"briefTitle":140,"officialTitle":141,"acronym":142,"eligibilityCriteria":143,"healthyVolunteers":144,"sex":145,"minAge":146,"maxAge":147,"enrollmentInfo":148,"targetDuration":18,"studyType":151,"phases":152,"briefSummary":154,"conditions":155,"keywords":18,"overallStatus":38,"whyStopped":18,"lastUpdateSubmitDate":158,"lastUpdatePostDateStruct":159,"startDateStruct":162,"completionDateStruct":164,"leadSponsor":165,"locationsCount":166},{"fullName":5,"class":6},"AGIR à Dom","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Physical activity","EXPERIMENTAL","Obstructive sleep apnea and resistant hypertension controlled + physical activity",[13],"Other: Physical activity",{"label":15,"type":16,"description":17,"interventionNames":18},"Control Group","NO_INTERVENTION","Obstructive sleep apnea and resistant hypertension controlled",null,[20],{"type":6,"name":9,"description":21,"armGroupLabels":22,"otherNames":18},"Physical activity will carry out 3 times per week during 12 weeks for intervention arm",[9],[24],{"name":25,"affiliation":26,"role":27},"Jean-Louis Pépin, Pr MD PhD","Laboratoire EFCR, CHU de Grenoble, 38043, Grenoble, France","PRINCIPAL_INVESTIGATOR",[29,32],{"name":25,"role":30,"phone":18,"phoneExt":18,"email":31},"CONTACT","JPepin@chu-grenoble.fr",{"name":33,"role":30,"phone":18,"phoneExt":18,"email":34},"Sandrine Bouzon","sbouzon@chu-grenoble.fr",[36,61,87,112,123],{"facility":37,"status":38,"city":39,"state":18,"zip":18,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ)","RECRUITING","Québec","Canada","CA",{"type":43,"coordinates":44},"Point",[45,46],-71.21454,46.81228,{"lat":46,"lon":45},[49,52,54,57,59],{"name":50,"role":30,"phone":18,"phoneExt":18,"email":51},"Simon Gakwaya","Simon.Gakwaya@criucpq.ulaval.ca",{"name":53,"role":27,"phone":18,"phoneExt":18,"email":18},"Caroline Minville, MD",{"name":55,"role":56,"phone":18,"phoneExt":18,"email":18},"Frédéric Sériès, MD","SUB_INVESTIGATOR",{"name":58,"role":56,"phone":18,"phoneExt":18,"email":18},"Isabelle Boutin, MD",{"name":60,"role":56,"phone":18,"phoneExt":18,"email":18},"François Maltais, MD",{"facility":62,"status":38,"city":63,"state":18,"zip":64,"country":65,"countryCode":66,"cosmosGeoPoint":67,"geoPoint":71,"contacts":72},"Hopital Universitaire de Grenoble","La Tronche","38700","France","FR",{"type":43,"coordinates":68},[69,70],5.74629,45.20507,{"lat":70,"lon":69},[73,75,76,77,79,81,83,85],{"name":74,"role":30,"phone":18,"phoneExt":18,"email":31},"Jean-Louis Pépin, MD PhD",{"name":33,"role":30,"phone":18,"phoneExt":18,"email":34},{"name":25,"role":27,"phone":18,"phoneExt":18,"email":18},{"name":78,"role":56,"phone":18,"phoneExt":18,"email":18},"Renaud Tamisier, Pr MD PhD",{"name":80,"role":56,"phone":18,"phoneExt":18,"email":18},"Patrick Lévy, Pr MD PhD",{"name":82,"role":56,"phone":18,"phoneExt":18,"email":18},"Jean-Philippe Baguet, Pr MD PhD",{"name":84,"role":56,"phone":18,"phoneExt":18,"email":18},"Sandrine Launois, MD PhD",{"name":86,"role":56,"phone":18,"phoneExt":18,"email":18},"Olivier Ormezzano, MD PhD",{"facility":88,"status":38,"city":89,"state":18,"zip":90,"country":65,"countryCode":66,"cosmosGeoPoint":91,"geoPoint":95,"contacts":96},"Clinique Pasteur","Toulouse","31300",{"type":43,"coordinates":92},[93,94],1.44367,43.60426,{"lat":94,"lon":93},[97,101,102,104,106,108,110],{"name":98,"role":30,"phone":99,"phoneExt":18,"email":100},"Atul Pathak, MD PhD","+33 5 62 21 21 14","apathak@clinique-pasteur.com",{"name":98,"role":27,"phone":18,"phoneExt":18,"email":18},{"name":103,"role":56,"phone":18,"phoneExt":18,"email":18},"Laurence Adrover, MD PhD",{"name":105,"role":56,"phone":18,"phoneExt":18,"email":18},"Nicolas Combes, MD PhD",{"name":107,"role":56,"phone":18,"phoneExt":18,"email":18},"Isabelle Billiart, MD PhD",{"name":109,"role":56,"phone":18,"phoneExt":18,"email":18},"David Attias, MD PhD",{"name":111,"role":56,"phone":18,"phoneExt":18,"email":18},"Pierre Morinet, MD PhD",{"facility":113,"status":114,"city":115,"state":18,"zip":18,"country":116,"countryCode":117,"cosmosGeoPoint":118,"geoPoint":122,"contacts":18},"Hopitaux Universitaires de Genève","WITHDRAWN","Geneva","Switzerland","CH",{"type":43,"coordinates":119},[120,121],6.14569,46.20222,{"lat":121,"lon":120},{"facility":124,"status":114,"city":125,"state":18,"zip":18,"country":116,"countryCode":117,"cosmosGeoPoint":126,"geoPoint":130,"contacts":18},"Centre Hospitalier Universitaire Vaudois","Lausanne",{"type":43,"coordinates":127},[128,129],6.63282,46.516,{"lat":129,"lon":128},{"type":132,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[134],{"name":135,"class":6},"University Hospital, Grenoble","100213607","physical-activity-program-for-reducing-blood-pressure-in-sleep-apnea-patients-with-resistant-hypertension-100213607",false,"NCT02057783","Physical Activity Program for Reducing Blood Pressure in Sleep Apnea Patients With Resistant Hypertension","Comparison of Standard Treatment by Continuous Positive Airway Pressure (CPAP) and CPAP Combined to a Physical Activity Program for Reducing Blood Pressure in Sleep Apnea Patients With Resistant Hypertension: RAP Randomized Controlled Trial","RAP","Inclusion Criteria:\n\n* Patient with an obstructive sleep apnea (apnea-hypopnea index \\> or equal to 15)\n* Patient with resistant hypertension uncontrolled by 3 or more antihypertensive agents\n* Ambulatory patient\n\nExclusion Criteria:\n\n* Acute hepatic failure, biliary cirrhosis, cholestasis\n* Acute hypertension (SBP\\>= 180 mmHg and\u002For DBP \\>= 110 mmHg)\n* Contraindication to CPAP treatment",true,"ALL","18 Years","80 Years",{"count":149,"type":150},100,"ESTIMATED","INTERVENTIONAL",[153],"NA","Investigators hypothesize that CPAP treatment for suppressing OSAS in combination with a physical activity program will optimize 24-hour blood pressure control in patients with OSA-related resistant hypertension.",[156,157],"Hypertension, Resistant to Conventional Therapy","Sleep Apnea","2025-02-18",{"date":160,"type":161},"2025-02-20","ACTUAL",{"date":163,"type":161},"2015-03-26",{"date":158,"type":150},{"name":5,"class":6},5]